Tufts engineers bacteria to produce rare healthy sugar

Scientists at Tufts University have developed a method using genetically modified bacteria to efficiently produce tagatose, a rare sugar that mimics table sugar's taste with fewer health risks. This breakthrough could provide a low-calorie alternative that supports oral and gut health without spiking blood sugar. The innovation achieves yields up to 95 percent, far surpassing traditional production techniques.

For over a century, researchers have sought sugar substitutes that deliver sweetness without the calories, tooth decay, and risks of obesity and diabetes linked to sucrose. A new study from Tufts University brings a promising solution: biosynthetic production of tagatose, a naturally rare sugar found in tiny amounts in dairy and fruits like apples and pineapples.

Tagatose offers 92 percent of sucrose's sweetness but with about 60 percent fewer calories. Classified by the FDA as "generally recognized as safe," it is absorbed minimally in the small intestine and fermented by gut bacteria, resulting in little impact on blood glucose or insulin levels. Studies show it limits cavity-causing oral bacteria and may promote beneficial microbes in the mouth and gut.

The Tufts team, led by Nik Nair, associate professor of chemical and biological engineering, engineered Escherichia coli bacteria as "tiny factories." They incorporated a slime mold enzyme, galactose-1-phosphate-selective phosphatase (Gal1P), to convert abundant glucose into galactose, followed by arabinose isomerase to yield tagatose. "There are established processes to produce tagatose, but they are inefficient and expensive," Nair said. This method boosts yields to 95 percent, compared to 40-77 percent in prior techniques, making it more economical.

Unlike high-intensity sweeteners, tagatose acts as a bulk sweetener, browning like sugar when heated and matching its mouthfeel. "The key innovation... was in finding the slime mold Gal1P enzyme and splicing it into our production bacteria," Nair explained. Published in Cell Reports Physical Science in 2025, the research could enable efficient synthesis of other rare sugars, potentially transforming food production for healthier options.

Related Articles

Illustration of Australian scientists developing antibodies targeting bacteria-specific sugar to treat drug-resistant infections in mice.
Image generated by AI

Australian team develops antibodies targeting a bacteria-only sugar, clearing drug-resistant infection in mice

Reported by AI Image generated by AI Fact checked

Australian researchers report they have engineered monoclonal antibodies that recognize pseudaminic acid—a sugar made by bacteria but not by humans—and used them to help eliminate multidrug-resistant Acinetobacter baumannii infections in mice, a step toward potential passive-immunotherapy treatments for hard-to-treat hospital infections.

Researchers at the University of Waterloo have developed engineered bacteria designed to invade and eat solid tumors from the inside out. The approach uses microbes that thrive in oxygen-free environments, targeting the low-oxygen cores of tumors. A genetic modification allows the bacteria to survive near oxygenated edges, controlled by a quorum-sensing mechanism.

Reported by AI Fact checked

Researchers at the Massachusetts Institute of Technology report that intelectin-2, a carbohydrate-binding lectin found in the gastrointestinal tract, can both crosslink mucus components to reinforce the gut’s protective barrier and bind certain bacteria, restricting their growth and reducing viability—findings that may inform future approaches to drug-resistant infections and inflammatory bowel disease.

Researchers have identified a novel UV-blocking compound produced by heat-loving cyanobacteria from hot springs in Thailand. This biocompatible molecule, triggered by UV light and salt stress, could pave the way for eco-friendly sunscreens. The discovery highlights unique adaptations in extremophilic microbes.

Reported by AI

Researchers at the University of Technology Sydney have created experimental compounds that prompt mitochondria to burn more calories safely. These mild mitochondrial uncouplers could offer a new approach to treating obesity without the deadly risks of past chemicals. The findings, published in Chemical Science, highlight potential benefits for metabolic health and aging.

Researchers at Texas A&M University have developed a chemogenetic system that uses caffeine to activate CRISPR gene editing in cells, potentially aiding treatments for cancer and diabetes. The method allows precise control over gene modifications by consuming small amounts of caffeine from everyday sources like coffee or chocolate. This approach aims to enhance immune responses and insulin production with reversible activation.

Reported by AI

Researchers in Israel have used CRISPR gene editing to deactivate a gene that produces bitter chemicals in grapefruit, potentially making the fruit more appealing to consumers. This innovation could expand the market for citrus and combat the devastating citrus greening disease by enabling cold-hardy, edible varieties. The approach aims to shift citrus farming to temperate regions like northern Europe.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline